Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on Jul... ( ...)

Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009

Date:7/22/2009

THE WOODLANDS, Texas, July 22 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its second quarter 2009 financial results on Tuesday, July 28, 2009 before the financial markets open. Lexicon management will hold a conference call to discuss its clinical development progress and financial results for second quarter 2009 at 11:00 a.m. Eastern Time on July 28, 2009.

The dial-in number for the conference call is 888-220-1244 (within the US/Canada) or 706-679-5615 (international). The conference ID for all callers is 17788499. Investors can access a live webcast of the call at www.lexpharma.com. An archived version of the webcast will be available on the website through August 4, 2009.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, carcinoid syndrome, diabetes, glaucoma and irritable bowel syndrome, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's g
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
2. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
3. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
4. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
5. Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available Online
6. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
7. Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
8. Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
9. Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
10. Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference
11. Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results

Post Your Comments:

(Date:11/20/2009)...TTLER TOLEDO recently announced that a free webina...Using At-Line Particle Characterization”, wi...nar, the application of in situ particle character...d optimize a series of roller compaction runs whil...mpaction forces. , (PRWEB...

(Date:11/19/2009)... Omeros Corporation (Nasd...sults for the third quarter ended September 30, 20... Omeros reported a net loss of $3.9 million, or $1...illion, or $2.54 per share, for the same period in...9, the Company reported a net loss of $15.5 millio...

(Date:11/19/2009)...v. 19 Spherix Incorporat... for diabetes therapy, and a provider of technical...ement, biotechnology and pharmaceutical companies,...eeting of Shareholders. ,, At the meeting, shar...elected the following members to the Board of Dire...

(Date:11/19/2009)...p LASIK surgeons and recognized refractive and cat...eons made brought their fellow surgeons up-to-date...urgery, cataract surgery, and ophthalmology in gen... Ophthalmology (AAO) annual meeting in San Francis... Tauber, Dr. David Huang, MD, Dr. Randy Epstein, D...

[0] Roller Compaction Process Optimization Using At-Line Particle Characterization [0] Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights [0] Spherix Announces Results of Annual Shareholders Meeting [0] Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting

...Jan. 17 The Science and Technology Foundation of,...he 2008 (24th) Japan,Prize today., All three laur...Dr.,Vinton Gray Cerf and Dr. Robert Elliot Kahn wh...chitecture and communication protocol for the,Inte...ication Theory and,Technology", and Dr. Victor A. ...

...Executive Brings Both Clinical Trial Experience an...ial Services Management Role, CAMBRIDGE, Mass., J...research and business development executive Irving...ytel Clinical Research Services.,Mr. Dark brings t...drug,biologic and medical device products successf...

...Switzerland, Jan. 16 Roche (OTCQX:,RHHBY; SWX: RO...f,pharmaceuticals and diagnostics, announced today...the outstanding common shares of Ventana Medical,S...rk City time on Friday,March 14, 2008. The tender ....m., New York City time, on January 17, 2008. All ...

Other Biology Technology:American Scientists Named as Laureates of the 2008 (24th) Japan Prize 2 Irving Dark Named Vice President of Cytel Clinical Research Services 2 Roche Extends Tender Offer for Ventana 2 Roche Extends Tender Offer for Ventana 3 Roche Extends Tender Offer for Ventana 4 Roche Extends Tender Offer for Ventana 5

American Scientists Named as Laureates of the 2008 (24th) Japan Prize Irving Dark Named Vice President of Cytel Clinical Research Services Roche Extends Tender Offer for Ventana

(Date:11/19/2009)...e Jaffrey Receives Competitive NIH Director,s T-R0...Glow in the Dark , Dr. Samie Jaffrey, associate ... College, is among the first researchers to win a ...d from the National Institutes of Health. Dr. Jaff...rotein recognition technologies that may some day ...

(Date:11/19/2009)...ARK, Md.-John Fisher, associate professor in the F... Inventor Pitch at the 2009 Bioscience Research an...bioreactor system that grows bone and other types ...y was one of six innovations presented in an eight...ents at the Professor Venture Fair, held November ...

(Date:11/19/2009)... LAFAYETTE, Ind. - Researchers have shown how an e...ves damaged in spinal cord injuries by preventing ...s" in the fibers are exposed. , The chemical com...ultiple sclerosis. , Because nerves usually are ..., called "compression" injuries, the drug offers h...

Breaking Biology News(10 mins):Weill Cornell science briefs: November 2009 2 Weill Cornell science briefs: November 2009 3 Weill Cornell science briefs: November 2009 4 Weill Cornell science briefs: November 2009 5 Bioreactor for bone tissue engineering wins professor venture fair 2 Bioreactor for bone tissue engineering wins professor venture fair 3 Drug studied as possible treatment for spinal injuries 2 Drug studied as possible treatment for spinal injuries 3 New Evidence Shakes Up Perceptions of Salt 59492 1 New Evidence Shakes Up Perceptions of Salt 59492 2 New Evidence Shakes Up Perceptions of Salt 59492 3 New Evidence Shakes Up Perceptions of Salt 59492 4 Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 1 Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 2 Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 3 4th Annual Spectrum Open 3A A Big Success 59487 1 4th Annual Spectrum Open 3A A Big Success 59487 2

[0] Weill Cornell science briefs: November 2009 [0] Bioreactor for bone tissue engineering wins professor venture fair [0] Drug studied as possible treatment for spinal injuries

...at least once a week displayed higher cognitive sk...s frequently, according to a study of nearly 4,000...aediatrica . , Eating fish once a week was enou...ntelligence scores by an average of six per cent, ...them by just under 11 per cent. , Swedish researc...

...DNA put scientists from the University of Bonn on ... occurs with significantly higher frequency in pe... group. The results are to be published in the for... Cleft lips and palates are among the most freque...n Central Europe are affected. Children in particu...

...fornia, San Diego, offer a new explanation for an ...s found along the Malay Peninsula in southeast Asi... absence of any geographical barrier. , An ancien...man Sea was once thought have split the peninsula ...to diverge. But a recent revision of the history o...

Other Biology News:Teenage boys who eat fish at least once a week achieve higher intelligence scores 2 Teenage boys who eat fish at least once a week achieve higher intelligence scores 3 Cleft lip and palate: Genes more important than thought? 2 New explanation for a puzzling biological divide along the Malay Peninsula 2

Teenage boys who eat fish at least once a week achieve higher intelligence scores Cleft lip and palate: Genes more important than thought?New explanation for a puzzling biological divide along the Malay Peninsula

Propidium Iodide from GeneTex

Death Check III Assay System (Caspase/Cell Viability) from Promega

Normal Bovine Serum from Equitech-Bio

DAPI/Antifade Solution from CHEMICON

Biology Products:

Propidium Iodide from GeneTex Death Check III Assay System (Caspase/Cell Viability) from Promega Normal Bovine Serum from Equitech-Bio DAPI/Antifade Solution from CHEMICON

Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on Jul...( ...)